ACI
VRTX icon

Alpha Cubed Investments’s Vertex Pharmaceuticals VRTX Stock Holding History

Alpha Cubed Investments’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-511
Closed -$248K – 324
2025
Q1 		$248K Sell
511
-267
-34% -$124K 0.01% 243
2024
Q4 		$313K Sell
778
-97
-11% -$45K 0.01% 200
2024
Q3 		$407K Sell
875
-107
-11% -$51.4K 0.02% 171
2024
Q2 		$460K Buy
982
+104
+12% +$45.1K 0.02% 163
2024
Q1 		$367K Buy
+878
New +$371K 0.02% 180

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Alpha Cubed Investments's VRTX Position: Q2 2025 in Review

Alpha Cubed Investments sold out of Vertex Pharmaceuticals (VRTX) in Q2 2025, closing a stake of 511 shares — an estimated $248K sold.

Alpha Cubed Investments first reported a position in VRTX in Q1 2024 and held it in 5 quarters. The position peaked at $460K in Q2 2024. 1,559 funds tracked by Wall St. Rank hold VRTX as of Q2 2025.

  • Alpha Cubed Investments reported no remaining Vertex Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Alpha Cubed Investments sold 511 Vertex Pharmaceuticals shares in Q2 2025, an estimated $248K.
  • Alpha Cubed Investments first reported a position in Vertex Pharmaceuticals in Q1 2024 and held it in 5 quarters.
  • Alpha Cubed Investments's Vertex Pharmaceuticals position peaked at $460K in Q2 2024.
  • 1,559 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2025.

Based on Alpha Cubed Investments's 13F filing for Q2 2025, filed 7 Aug 2025.